These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37287535)

  • 1. Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
    Wu Y; Zhang B; Nong J; Alarcon Rodriguez R; Guo W; Liu Y; Zhao S; Wei R
    Front Genet; 2023; 14():1204421. PubMed ID: 37287535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
    Wu Y; Zhang B; Nong J; Rodrìguez RA; Guo W; Liu Y; Zhao S; Wei R
    Front Genet; 2023; 14():1045061. PubMed ID: 37035741
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolyl 4-hydroxylase subunit alpha 3 presents a cancer promotive function in head and neck squamous cell carcinoma via regulating epithelial-mesenchymal transition.
    Wang T; Wang YX; Dong YQ; Yu YL; Ma K
    Arch Oral Biol; 2020 May; 113():104711. PubMed ID: 32220804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway.
    Zhou H; Zou J; Shao C; Zhou A; Yu J; Chen S; Xu C
    Pathol Res Pract; 2022 Feb; 230():153749. PubMed ID: 34959098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma.
    Huang J; Zhao P; Shi J; Ning J; Wang Z; Luo Y; Qin J; Huang X
    Int J Gen Med; 2023; 16():1953-1971. PubMed ID: 37251280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer.
    Niu X; Ren L; Wang S; Gao D; Ma M; Hu A; Qi H; Zhang S
    Front Genet; 2022; 13():952335. PubMed ID: 35846138
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3.
    Zhou H; Huang S; Shao C; Zou J; Zhou A; Yu J; Xu C
    Anal Cell Pathol (Amst); 2022; 2022():1542117. PubMed ID: 35433237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.
    Song H; Liu L; Song Z; Ren Y; Li C; Huo J
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818796485. PubMed ID: 30198421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway.
    Long R; Liu Z; Li J; Yu H
    Aging (Albany NY); 2019 Oct; 11(20):8845-8859. PubMed ID: 31627190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancers.
    Nakasuka F; Tabata S; Sakamoto T; Hirayama A; Ebi H; Yamada T; Umetsu K; Ohishi M; Ueno A; Goto H; Sugimoto M; Nishioka Y; Yamada Y; Tomita M; Sasaki AT; Yano S; Soga T
    Commun Biol; 2021 Jun; 4(1):782. PubMed ID: 34168290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells.
    Luo Y; Xu W; Chen H; Warburton D; Dong R; Qian B; Selman M; Gauldie J; Kolb M; Shi W
    J Pathol; 2015 Jul; 236(3):384-94. PubMed ID: 25779936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Zhang Y; Zhang X; Huang X; Tang X; Zhang M; Li Z; Hu X; Zhang M; Wang X; Yan Y
    Stem Cell Res Ther; 2023 Feb; 14(1):15. PubMed ID: 36721217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.
    Atkinson A; Renziehausen A; Wang H; Lo Nigro C; Lattanzio L; Merlano M; Rao B; Weir L; Evans A; Matin R; Harwood C; Szlosarek P; Pickering JG; Fleming C; Sim VR; Li S; Vasta JT; Raines RT; Boniol M; Thompson A; Proby C; Crook T; Syed N
    J Invest Dermatol; 2019 May; 139(5):1118-1126. PubMed ID: 30452903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer.
    Zhang M; Liu Y; Liu Y; Hou S; Li H; Ma Y; Wang C; Chen X
    Front Genet; 2022; 13():978493. PubMed ID: 36092866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes.
    Zhuang L; Li C; Hu X; Yang Q; Pei X; Jin G
    Braz J Med Biol Res; 2022; 55():e11741. PubMed ID: 35976267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.
    Shi D; Mu S; Pu F; Zhong B; Hu B; Muhtar M; Tong W; Shao Z; Zhang Z; Liu J
    Cell Mol Life Sci; 2022 Jul; 79(8):427. PubMed ID: 35842562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
    Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
    Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
    Wang G; Xu D; Zhang Z; Li X; Shi J; Sun J; Liu HZ; Li X; Zhou M; Zheng T
    NPJ Precis Oncol; 2021 Jun; 5(1):56. PubMed ID: 34158591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.